Financhill
Back

Xeris Biopharma Holdings 10K Form

Buy
59

XERS
Xeris Biopharma Holdings

Last Price:
$4.38
Seasonality Move:
-6.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive XERS News And Ratings

See the #1 stock for the next 7 days that we like better than XERS

XERS Financial Statistics

Sales & Book Value

Annual Sales: $203.1M
Cash Flow: $-10M
Price / Cash Flow: 0
Annual Sales: $-0.23
Price / Book: 0

Profitability

EPS (TTM): -0.30000
Net Income (TTM): $-45.1M
Gross Margin: $166.2M
Return on Equity: -1019.2%
Return on Assets: -13.84%

Xeris Biopharma Holdings Earnings Forecast

Key Xeris Biopharma Holdings Financial Ratios

  • The Gross Profit Margin over the past 9 years for XERS is 81.86%.
  • The Selling, General & Administrative Expenses for XERS have been equal to 80.50% of Gross Profit Margin.
  • The Research & Development expenses have been 12.59% of Revenue.
  • The Net Earning history of XERS is -27.00% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 7 years.

Xeris Biopharma Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: XERS
CUSIP: 98422L
Website: xerispharma.com

Debt

Debt-to-Equity Ratio: -6.54
Current Ratio: 1.72
Quick Ratio: 1.1

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 114.75

XERS Technical Analysis vs Fundamental Analysis

Buy
59
Xeris Biopharma Holdings (XERS) is a Buy

Is Xeris Biopharma Holdings a Buy or a Sell?